| Katherine Tchir, | |
|
851 Trafalgar Court Suite 200e, Maitland, FL 32751 | |
| (407) 667-0444 | |
| Not Available |
| Full Name | Katherine Tchir |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 4 Years |
| Location | 851 Trafalgar Court Suite 200e, Maitland, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821616228 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lee Memorial Hospital | Fort myers, FL | Hospital |
| Cape Coral Hospital | Cape coral, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Us Anesthesia Partners Of Florida Inc | 0345143152 | 786 |
News Archive
The use of orally activated Xa antagonist and direct thrombin inhibitors is associated with a significant increase in major bleeding events in acute coronary syndrome patients, a study shows.
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who've had too much exposure to the glare of electronic screens.
› Verified 9 days ago
| Entity Name | Us Anesthesia Partners Of Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518910520 PECOS PAC ID: 0345143152 Enrollment ID: O20040129000594 |
News Archive
The use of orally activated Xa antagonist and direct thrombin inhibitors is associated with a significant increase in major bleeding events in acute coronary syndrome patients, a study shows.
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who've had too much exposure to the glare of electronic screens.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Tchir, 1132 Nw 174 Ave, Pembroke Pines, FL 33029 Ph: () - | Katherine Tchir, 851 Trafalgar Court Suite 200e, Maitland, FL 32751 Ph: (407) 667-0444 |
News Archive
The use of orally activated Xa antagonist and direct thrombin inhibitors is associated with a significant increase in major bleeding events in acute coronary syndrome patients, a study shows.
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who've had too much exposure to the glare of electronic screens.
› Verified 9 days ago
Andrea Cazares, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 851 Trafalgar Ct Ste 200e, Maitland, FL 32751 Phone: 407-667-0444 Fax: 407-667-4338 | |
Mr. Zachary Tear Gaudette, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 851 Trafalgar Court, Suite 200e, Maitland, FL 32751 Phone: 260-425-6030 | |
Akeal Sheikh, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 851 Trafalgar Ct Ste 200e, Maitland, FL 32751 Phone: 888-339-8727 | |
Brooke Alexandria Parisian, AA Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 851 Trafalgar Ct Ste 300w, Maitland, FL 32751 Phone: 407-896-9500 | |
Diana Perez, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 851 Trafalgar Ct Ste 200e, Maitland, FL 32751 Phone: 321-422-7166 |